Products

Image description

FDA approves GSK's Arnuity Ellipta

GlaxoSmithKline announced FDA approval for Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid medicine for the treatment of asthma in patients 12 years of age and older.

Image description

Sensory delivery becomes trendy

Pharmavite’s VitaMelts brand has been a popular introduction to the category, with $9.4 million in sales, up 184.3%, for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

Image description

Estroven attracts new users

The successful introduction of Estroven Weight Management is bringing new users to the menopause supplement category, said April Mills, marketing director of i-Health, a division of DSM.

Image description

Bayer’s ‘Next’ big thing

Bayer Diagnostics’ Contour Next portfolio has been performing exceptionally well lately, generating $12.4 million in front-end sales, up 226.6% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

Image description

Switch-up for the ‘Purple Pill’

Pfizer successfully switched Nexium to over-the-counter in late May, and with that brought a $6 billion book of prescription business to antacid aisles, according to IMS Health data compiled over 2012.